Skip to content
Coalition for Epidemic Preparedness Innovations (CEPI)
-
CEPI pledges US$60M to fast-track Bundibugyo Ebola vaccines from Moderna, Oxford, and IAVI
The funding will support three promising vaccine candidates being developed by Moderna, the University of Oxford in partnership with the Serum Institute of India, and the International AIDS Vaccine Initiative (IAVI).
-
Oxford/CEPI Lassa vaccine enters clinical trial in Nigeria
Experts project that up to 700 million people could inhabit areas vulnerable to Lassa fever by 2070.